Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 49: 761-768, 2003; 10.1373/49.5.761
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tammaro, A.
Right arrow Articles by Nigro, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tammaro, A.
Right arrow Articles by Nigro, V.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2003;49:761-768.)
© 2003 American Association for Clinical Chemistry, Inc.

Scanning for Mutations of the Ryanodine Receptor (RYR1) Gene by Denaturing HPLC: Detection of Three Novel Malignant Hyperthermia Alleles

Angela Tammaro1, Adele Bracco1, Santolo Cozzolino1, Maria Esposito2, Antonietta Di Martino1, Gennaro Savoia1, Laura Zeuli1, Giulio Piluso3, Stefania Aurino2 and Vincenzo Nigro2,3,a

1 Malignant Hyperthermia Center, AO Cardarelli, via San Giacomo dei Capri 66, 80131 Napoli, Italy.

2 Telethon Institute. of Genetics and Medicine (TIGEM), via Pietro Castellino 111, 80131 Napoli, Italy

3 Dipartimento di Patologia Generale e Centro di Eccellenza sulle Malattie Cardiovascolari, Seconda Università degli Studi di Napoli, via Luigi De Crecchio 7, 80138 Napoli, Italy.

aAddress correspondence to this author at: Dipartimento di Patologia Generale, Seconda Università degli Studi di Napoli, via Luigi De Crecchio 7, 80138 Napoli, Italy. Fax 39-081-5665704; e-mail vincenzo.nigro{at}unina2.it.

Background: Malignant hyperthermia (MH) is a fatal autosomal dominant pharmacogenetic disorder characterized by skeletal muscle hypertonicity that causes a sudden increase in body temperature after exposure to common anesthetic agents. The disease is genetically heterogeneous, with mutations in the gene encoding the skeletal muscle ryanodine receptor (RYR1) at 19q13.1 accounting for up to 80% of the cases. To date, at least 42 RYR1 mutations have been described that cause MH and/or central core disease. Because the RYR1 gene is huge, containing 106 exons, molecular tests have focused on the regions that are more frequently mutated. Thus the causative defect has been identified in only a fraction of families as linked to chromosome 19q, whereas in others it remains undetected.

Methods: We used denaturing HPLC (DHPLC) to analyze the RYR1 gene. We set up conditions to scan the 27 exons to identify both known and unknown mutations in critical regions of the protein. For each exon, we analyzed members from 52 families with positive in vitro contracture test results, but without preliminary selection by linkage analysis.

Results: We identified seven different mutations in 11 MH families. Among them, three were novel MH alleles: Arg44Cys, Arg533Cys, and Val2117Leu.

Conclusion: Because of its sensitivity and speed, DHPLC could be the method of choice for the detection of unknown mutations in the RYR1 gene.




The following articles in journals at HighWire Press have cited this article:


Home page
 Anesth. Analg.Home page
S. Levano, D. Keller, E. Schobinger, A. Urwyler, and T. Girard
Rapid and Accurate Detection of Atypical and Kalow Variants in the Butyrylcholinesterase Gene Using Denaturing High Performance Liquid Chromatography
Anesth. Analg., January 1, 2008; 106(1): 147 - 151.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
H.-M. Yeh, M.-C. Tsai, Y.-N. Su, R.-C. Shen, J.-J. Hwang, W.-Z. Sun, and L.-P. Lai
Denaturing High Performance Liquid Chromatography Screening of Ryanodine Receptor Type 1 Gene in Patients with Malignant Hyperthermia in Taiwan and Identification of a Novel Mutation (Y522C)
Anesth. Analg., November 1, 2005; 101(5): 1401 - 1406.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Kobayashi, M. L. Bannister, J. P. Gangopadhyay, T. Hamada, J. Parness, and N. Ikemoto
Dantrolene Stabilizes Domain Interactions within the Ryanodine Receptor
J. Biol. Chem., February 25, 2005; 280(8): 6580 - 6587.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Bagattin, C. Veronese, B. Bauce, W. Wuyts, L. Settimo, A. Nava, A. Rampazzo, and G. A. Danieli
Denaturing HPLC-Based Approach for Detecting RYR2 Mutations Involved in Malignant Arrhythmias
Clin. Chem., July 1, 2004; 50(7): 1148 - 1155.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.